HIGHLIGHTS
- who: September and collaborators from the United Kingdom United Kingdom have published the research: Features of the metabolic syndrome and subclinical atherosclerosis in patients with cerebrotendinous xanthomatosis: An augmented risk for premature cardiovascular disease, in the Journal: (JOURNAL)
- what: As the assessment for features of the metabolic syndrome and cIMT are not used in the routine management of CTX patients, the aim of this work was to evaluate the prevalence of MS and vascular changes in CTX in an attempt to elucidate the mechanism leading to the phenomena of premature CVD. The authors report here . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.